Studies show that regular use of GeloMyrtol ® forte has a positive effect on the progression of chronic bronchitis. The special distillate within these capsules plays a crucial role in activating the natural clearing of the airways. Pathogenesis and symptoms of many acute or chronic inflammatory processes are accompanied and/or initiated by the production of reactive oxygen species (ROS). Only Myrtol inhibited significantly the release of TNF-alpha and GM-CSF, indicating additionally an anti-inflammatory activity in comparison with eucalyptus oil and orange oil. Der therapeutische Nutzen kann höher sein, als das Risiko, das die Anwendung bei einer Gegenanzeige in sich birgt.

The natural self-cleaning powers of the airways are activated: The mucus in the bronchi and paranasal sinuses is loosened, the bronchi relax and the pathogens are fought. auch vor dem SchlafengehenKinder von 6-10 Jahren (mit 20-29 kg Körpergewicht)1 KapselKinder von 6-10 Jahren (mit 20-29 kg Körpergewicht)vor der Mahlzeit (ca. FOR CHILDREN FROM 6 YEARS OLD Children are particularly likely to have symptoms such as runny nose and cough, which can quickly develop into bronchitis. However, there is one case reported in the literature, where anaphylactic shock was developed after receiving a GeloMyrtol® forte capsule to treat an upper respiratory system infection. The majority of patients seek medical care within the 1 st week of the disease course to be relieved from the severity of their symptoms.You can change your choices at any time by visiting Cookie preferences, as described in the Cookie notice. It contains a standardized extract of Myrtol, a blend of essential oils with powerful anti-inflammatory and expectorant properties. If the infection has already spread, the herbal active ingredient loosens the mucus in the upper and lower airways. Patients with acute bronchitis, without significant comorbidities or relevant comedication, were enrolled and divided into two groups, those receiving placebo and those treated with GeloMyrtol® forte 300 mg four times daily.

crushed and uncrushed in a randomized way on four different days with an interval of 6 days without any therapy. Effect of myrtol standardized and other substances on the respiratory tract: Ciliary beat frequency and mucociliary clearance as parameters. For instance, in ARS, the incidence of bacterial infections is estimated to be only 2–10%, with a secondary bacterial infection occurring only in 0.However, the administration of Myrtol® standardized significantly attenuated the MUC5AC hypersecretion and reduced the production of IL-6 and TNF-alpha in the PA infected lungs, indicating a secretolytic and anti-inflammatory effects. New with box: A brand-new, unused, unworn and undamaged item in its original packaging (such as the . In patients with chronic bronchitis, it was possible to show in a large clinical study over 6 months that the administration of GeloMyrtol ® forte, the intensity and frequency of acute infections could be significantly reduced over the winter months. Therefore, long-term treatment with Myrtol® standardized in patients with chronic bronchitis is equally well tolerated as placebo, but is clearly superior in efficacy, in terms of protecting against acute exacerbations, reducing the frequency and intensity of acute exacerbations, the need of antibiotics during an exacerbation, and the health impairment by cough and expectoration. Clinical study of decoction of invigorating Qi and clearing lung combined standardized myrtol on acute exacerbation of chronic obstructive pulmonary disease (AECOPD) Zhongguo Zhong Yao Za Zhi.

This review gives an insight into the already proposed indications of Myrtol® standardized, involved pharmacodynamic mechanisms, and potential advantages toward antibiotic therapy, especially when bacterial infection is uncertain.This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3. Each gastro-resistant capsule contains a distillate of rectified eucalyptus oil, rectified orange oil, rectified myrtle oil, and rectified lemon oil. Itching, urticaria, and respiratory distress syndrome occurred 20 min after application of the medication, and prick tests were highly positive for the substance dibutyl phthalate, which is a plasticizer of capsule coating. auch vor dem SchlafengehenKinder von 6-10 Jahren (mit 20-29 kg Körpergewicht )1 KapselKinder von 6-10 Jahren (mit 20-29 kg Körpergewicht )vor der Mahlzeit (ca.

tested in a multicenter, randomized, double-blinded study, the efficacy and safety of Myrtol® standardized in patients with nonpurulent acute sinusitis, in comparison to placebo and other etheric oil with similar pharmacological activity. In 1989 he was awarded for a scholarship at the National Institutes of Health (NIH), Bethesda/Maryland/USA He is specialized in internal medicine, pulmonary medicine as well as in allergology and has a MSc in Pharmaceutical Medicine. who measured the mucociliary transport time (MTT) by acoustic rhinometry and active anterior rhinomanometry in patients with chronic nonallergic rhinitis after implementing saccharine test.Furthermore, the experimentally proven inhibition of the enzyme 5-lipoxygenase in leukemic basophil and eosinophil leukocytes of rats and the production of prostaglandin E2 in mucous membranes of teat cisterns after topical administration of TPA (tetradecanoylphorbol-13-acetate) indicate a wide range of anti-inflammatory potential by blocking many different inflammatory pathways. A Multi-centre, randomised, placebo-controlled, double-blind, repeated-dose, parallel group study to assess the efficacy and tolerability of Myrtol in patients with chronic sinusitis.